ALEXANDRA BANKER: Open Payments
NPI 1902323611 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 51 payments from 19 companies in 2025. Trend: 2023 $67 · 2024 $1,276 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $220 |
| ABBVIE INC. | 4 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Lilly USA, LLC | 4 | $74 |
| PFIZER INC. | 4 | $73 |
| Novo Nordisk Inc | 3 | $56 |
| Dexcom, Inc. | 2 | $49 |
| Abbott Laboratories | 2 | $44 |
| Viatris Specialty LLC | 2 | $41 |
Products named: AIRSUPRA, GEMTESA, Kerendia, NURTEC ODT, UBRELVY, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across MS — which companies pay providers there.
